Paul J. Clancy - Insider Trading & Ownership

Location
C/O Biogen Idec Inc., 14 Cambridge Center, Cambridge, MA
Summary
The estimated net worth of Paul J. Clancy is at least $3.62M dollars as of October 2, 2025. Paul J. Clancy is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.97M. Paul J. Clancy is the Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $1.39M. Paul J. Clancy is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $265K.
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All Insider Reports
All Insider Reports

Ownership of Paul J. Clancy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INCY INCYTE CORP Director $1.97M Sep 30, 2025
EXAS EXACT SCIENCES CORP Director $1.39M Jun 12, 2025
AGIO AGIOS PHARMACEUTICALS, INC. Director $265K Jun 21, 2022
SION Sionna Therapeutics, Inc. Director Jun 12, 2025
XLO Xilio Therapeutics, Inc. Director Jun 11, 2025

Insider Transactions Reported by Paul J. Clancy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.